Vigil Neuroscience Launches ALSPAware to Provide Access to
– New genetic testing initiative designed to enable improved patient diagnosis of ALSP, a devastating, rare genetic neurodegenerative disease – – Through...
Source: globenewswire.com
Page 42 - Sciences Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sciences Corp Today - Breaking & Trending Today
Vigil Neuroscience Launches ALSPAware to Provide Access to No-cost Genetic Testing and Counseling for Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)
– New genetic testing initiative designed to enable improved patient diagnosis of ALSP, a devastating, rare genetic neurodegenerative disease – – Through ALSPAware, individuals and... | May 8, 2023
Source: marketscreener.com
Exact Sciences (NASDAQ:EXAS) Receives New Coverage from Analysts at UBS Group
UBS Group started coverage on shares of Exact Sciences (NASDAQ:EXAS – Get Rating) in a research note released on Friday morning, The Fly reports. The brokerage issued a neutral rating and a $73.00 target price on the medical research company’s stock. A number of other equities research analysts have also commented on EXAS. Cowen increased […]
Source: wkrb13.com
Exact Sciences Co. (NASDAQ:EXAS) Position Boosted by Pictet & Cie Europe SA
Pictet & Cie Europe SA grew its position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 4.9% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 143,368 shares of the medical research company’s stock after purchasing an additional 6,655 shares during the period. Pictet & Cie Europe SA’s holdings in Exact Sciences were […]
Source: wkrb13.com
Robeco Institutional Asset Management B.V. Acquires 36,949 Shares of Exact Sciences Co. (NASDAQ:EXAS)
Robeco Institutional Asset Management B.V. boosted its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 727.8% during the fourth quarter, HoldingsChannel reports. The fund owned 42,026 shares of the medical research company’s stock after purchasing an additional 36,949 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Exact Sciences […]
Source: etfdailynews.com